NBIX vs PDD · P/E 45, rev $1.77B vs P/E 8.4, rev $61.75B
Neurocrine Biosciences Inc (NBIX) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the NBIX and PDD stock pages for the full models.
Not investment advice.